[8-K] Perspective Therapeutics, Inc. Reports Material Event
Perspective Therapeutics, Inc. reported that it issued a press release announcing its financial results for the quarter ended June 30, 2025 and furnished that press release as Exhibit 99.1 to this Form 8-K. The filing also states the company posted an updated corporate presentation on its website and furnished that presentation as Exhibit 99.2. The 8-K clarifies that the information is "furnished" and therefore is not deemed "filed" for purposes of Section 18 of the Exchange Act.
The filing text does not include the actual financial figures or metrics; those details are contained in the referenced exhibits. This disclosure informs investors that quarter-end results and investor materials have been released, while the legal notice about furnishing limits incorporation and Section 18 liability.
Perspective Therapeutics, Inc. ha comunicato con un comunicato stampa i risultati finanziari per il trimestre chiuso il 30 giugno 2025 e ha allegato tale comunicato come Exhibit 99.1 al presente Modulo 8鈥慘. La societ脿 dichiara inoltre di aver pubblicato una presentazione aziendale aggiornata sul proprio sito web e di averla fornita come Exhibit 99.2. L'8鈥慘 precisa che le informazioni sono "furnished" e quindi non sono considerate "filed" ai sensi della Sezione 18 dell'Exchange Act.
Il testo della segnalazione non contiene le cifre o i dati finanziari effettivi; tali dettagli sono riportati negli exhibit richiamati. Questa comunicazione informa gli investitori della pubblicazione dei risultati di fine trimestre e del materiale per gli investitori, mentre l'avvertenza legale sulla natura "furnished" limita l'incorporazione nel documento e la responsabilit脿 ai sensi della Sezione 18.
Perspective Therapeutics, Inc. inform贸 mediante un comunicado de prensa sus resultados financieros del trimestre cerrado el 30 de junio de 2025 y adjunt贸 ese comunicado como Exhibit 99.1 en este Formulario 8鈥慘. La presentaci贸n tambi茅n indica que la compa帽铆a public贸 en su web una presentaci贸n corporativa actualizada y la incluy贸 como Exhibit 99.2. El 8鈥慘 aclara que la informaci贸n est谩 "furnished" y, por tanto, no se considera "filed" a efectos de la Secci贸n 18 del Exchange Act.
El texto de la presentaci贸n no contiene las cifras o m茅tricas financieras reales; esos detalles est谩n en los exhibits referenciados. Esta divulgaci贸n informa a los inversores sobre la publicaci贸n de los resultados del trimestre y de los materiales para inversores, mientras que el aviso legal sobre el car谩cter "furnished" limita su incorporaci贸n y la responsabilidad conforme a la Secci贸n 18.
Perspective Therapeutics, Inc.電� 2025雲� 6鞗� 30鞚� 膦呺 攵勱赴鞚� 鞛 鞁れ爜鞚� 氚滍憸頃橂姅 氤措弰鞛愲毳� 氚绊彫頄堨溂氅�, 頃措嫻 氤措弰鞛愲毳� 氤� Form 8鈥慘鞐� Exhibit 99.1搿� 鞝滌稖頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟. 霕愴暅 須岇偓電� 斓滌嫚 旮办梾 頂勲爤鞝犿厡鞚挫厴鞚� 鞗轨偓鞚错姼鞐� 瓴岇嫓頃橁碃 鞚措ゼ Exhibit 99.2搿� 鞝滌稖頄堧嫟瓿� 旮办灛頄堨姷雼堧嫟. 8鈥慘電� 頃措嫻 鞝曤炒臧� "furnished"搿� 鞝滉车霅橃柎 Exchange Act鞚� 靹轨厴 18靸� "filed"搿� 臧勳＜霅橃 鞎婋姅雼り碃 氇呿檿頌� 頃橁碃 鞛堨姷雼堧嫟.
鞁犼碃靹� 氤鸽鞐愲姅 鞁れ牅 鞛 靾橃箻雮� 歆�響滉皜 韽暔霅橃柎 鞛堨 鞎婌溂氅�, 頃措嫻 靹鸽秬 靷暛鞚� 彀胳“霅� 鞝勳嫓氍�(exhibits)鞐� 雼搓波 鞛堨姷雼堧嫟. 鞚� 瓿奠嫓電� 攵勱赴 毵� 鞁れ爜瓿� 韴瀽鞛愳毄 鞛愲臧� 瓿店皽霅橃棃鞚岇潉 鞎岆Μ電� 頃滍幐, "furnished"霛茧姅 氩曥爜 響滉赴臧� 氍胳劀鞚� 韽暔 氩旍渼鞕� 靹轨厴 18鞐� 霐半ジ 毂呾瀯鞚� 鞝滍暅頃潉 鞚橂頃╇媹雼�.
Perspective Therapeutics, Inc. a annonc茅 par communiqu茅 de presse ses r茅sultats financiers pour le trimestre clos le 30 juin 2025 et a joint ce communiqu茅 comme Exhibit 99.1 au pr茅sent Formulaire 8鈥慘. Le d茅p么t indique 茅galement que la soci茅t茅 a publi茅 une pr茅sentation d'entreprise mise 脿 jour sur son site web et l'a fournie comme Exhibit 99.2. Le 8鈥慘 pr茅cise que les informations sont "furnished" et ne sont donc pas r茅put茅es "filed" aux fins de la Section 18 de l'Exchange Act.
Le texte du d茅p么t n'inclut pas les chiffres ou indicateurs financiers r茅els ; ces d茅tails figurent dans les exhibits r茅f茅renc茅s. Cette divulgation informe les investisseurs de la publication des r茅sultats de fin de trimestre et des documents destin茅s aux investisseurs, tandis que l'avertissement juridique relatif au caract猫re "furnished" limite l'incorporation et la responsabilit茅 au titre de la Section 18.
Perspective Therapeutics, Inc. gab in einer Pressemitteilung seine Finanzergebnisse f眉r das zum 30. Juni 2025 endende Quartal bekannt und stellte diese Pressemitteilung als Exhibit 99.1 in diesem Form 8鈥慘 zur Verf眉gung. Die Einreichung f眉hrt zudem an, dass das Unternehmen eine aktualisierte Unternehmenspr盲sentation auf seiner Website ver枚ffentlicht und diese als Exhibit 99.2 bereitgestellt hat. Das 8鈥慘 stellt klar, dass die Informationen "furnished" sind und daher im Sinne von Section 18 des Exchange Act nicht als "filed" gelten.
Der Text der Einreichung enth盲lt nicht die tats盲chlichen Finanzzahlen oder Kennzahlen; diese Details stehen in den referenzierten Exhibits. Mit dieser Offenlegung werden Anleger dar眉ber informiert, dass Quartalszahlen und Investorenunterlagen ver枚ffentlicht wurden, w盲hrend der rechtliche Hinweis zur "furnished"-Natur die Einbeziehung in andere Dokumente und die Haftung nach Section 18 begrenzt.
- Press release issued announcing financial results for the quarter ended June 30, 2025 (furnished as Exhibit 99.1).
- Updated corporate presentation posted on the company website and furnished as Exhibit 99.2, providing investors with refreshed materials.
- Filing does not include in-line financial figures; quantitative results and metrics are only available in the referenced Exhibit 99.1.
- Information furnished, not filed, which the company states limits Section 18 liability and means the 8-K text is procedural rather than substantive.
Insights
TL;DR: Company furnished Q2 2025 results and an updated corporate presentation; the 8-K contains no financial figures in-line.
The filing confirms Perspective Therapeutics publicly released results for the quarter ended June 30, 2025 and provided an updated investor deck. From an analyst perspective, the 8-K itself offers procedural confirmation of distribution rather than substantive metrics; readers must review Exhibit 99.1 for earnings, revenues, cash position, or guidance. The statement that the materials are "furnished" (not "filed") limits Section 18 liability and means investors should treat the exhibits as the primary source for any quantitative assessment.
TL;DR: Routine investor communication: press release plus updated corporate presentation were posted and furnished as exhibits.
This 8-K reflects standard investor-relations practice: distribute quarter-end results and refresh the corporate presentation, then furnish both as exhibits. The filing explicitly references Exhibit 99.1 (press release) and Exhibit 99.2 (presentation). The notice that the items are "furnished" rather than "filed" is a common disclosure control measure; it does not by itself convey operational or financial performance details.
Perspective Therapeutics, Inc. ha comunicato con un comunicato stampa i risultati finanziari per il trimestre chiuso il 30 giugno 2025 e ha allegato tale comunicato come Exhibit 99.1 al presente Modulo 8鈥慘. La societ脿 dichiara inoltre di aver pubblicato una presentazione aziendale aggiornata sul proprio sito web e di averla fornita come Exhibit 99.2. L'8鈥慘 precisa che le informazioni sono "furnished" e quindi non sono considerate "filed" ai sensi della Sezione 18 dell'Exchange Act.
Il testo della segnalazione non contiene le cifre o i dati finanziari effettivi; tali dettagli sono riportati negli exhibit richiamati. Questa comunicazione informa gli investitori della pubblicazione dei risultati di fine trimestre e del materiale per gli investitori, mentre l'avvertenza legale sulla natura "furnished" limita l'incorporazione nel documento e la responsabilit脿 ai sensi della Sezione 18.
Perspective Therapeutics, Inc. inform贸 mediante un comunicado de prensa sus resultados financieros del trimestre cerrado el 30 de junio de 2025 y adjunt贸 ese comunicado como Exhibit 99.1 en este Formulario 8鈥慘. La presentaci贸n tambi茅n indica que la compa帽铆a public贸 en su web una presentaci贸n corporativa actualizada y la incluy贸 como Exhibit 99.2. El 8鈥慘 aclara que la informaci贸n est谩 "furnished" y, por tanto, no se considera "filed" a efectos de la Secci贸n 18 del Exchange Act.
El texto de la presentaci贸n no contiene las cifras o m茅tricas financieras reales; esos detalles est谩n en los exhibits referenciados. Esta divulgaci贸n informa a los inversores sobre la publicaci贸n de los resultados del trimestre y de los materiales para inversores, mientras que el aviso legal sobre el car谩cter "furnished" limita su incorporaci贸n y la responsabilidad conforme a la Secci贸n 18.
Perspective Therapeutics, Inc.電� 2025雲� 6鞗� 30鞚� 膦呺 攵勱赴鞚� 鞛 鞁れ爜鞚� 氚滍憸頃橂姅 氤措弰鞛愲毳� 氚绊彫頄堨溂氅�, 頃措嫻 氤措弰鞛愲毳� 氤� Form 8鈥慘鞐� Exhibit 99.1搿� 鞝滌稖頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟. 霕愴暅 須岇偓電� 斓滌嫚 旮办梾 頂勲爤鞝犿厡鞚挫厴鞚� 鞗轨偓鞚错姼鞐� 瓴岇嫓頃橁碃 鞚措ゼ Exhibit 99.2搿� 鞝滌稖頄堧嫟瓿� 旮办灛頄堨姷雼堧嫟. 8鈥慘電� 頃措嫻 鞝曤炒臧� "furnished"搿� 鞝滉车霅橃柎 Exchange Act鞚� 靹轨厴 18靸� "filed"搿� 臧勳＜霅橃 鞎婋姅雼り碃 氇呿檿頌� 頃橁碃 鞛堨姷雼堧嫟.
鞁犼碃靹� 氤鸽鞐愲姅 鞁れ牅 鞛 靾橃箻雮� 歆�響滉皜 韽暔霅橃柎 鞛堨 鞎婌溂氅�, 頃措嫻 靹鸽秬 靷暛鞚� 彀胳“霅� 鞝勳嫓氍�(exhibits)鞐� 雼搓波 鞛堨姷雼堧嫟. 鞚� 瓿奠嫓電� 攵勱赴 毵� 鞁れ爜瓿� 韴瀽鞛愳毄 鞛愲臧� 瓿店皽霅橃棃鞚岇潉 鞎岆Μ電� 頃滍幐, "furnished"霛茧姅 氩曥爜 響滉赴臧� 氍胳劀鞚� 韽暔 氩旍渼鞕� 靹轨厴 18鞐� 霐半ジ 毂呾瀯鞚� 鞝滍暅頃潉 鞚橂頃╇媹雼�.
Perspective Therapeutics, Inc. a annonc茅 par communiqu茅 de presse ses r茅sultats financiers pour le trimestre clos le 30 juin 2025 et a joint ce communiqu茅 comme Exhibit 99.1 au pr茅sent Formulaire 8鈥慘. Le d茅p么t indique 茅galement que la soci茅t茅 a publi茅 une pr茅sentation d'entreprise mise 脿 jour sur son site web et l'a fournie comme Exhibit 99.2. Le 8鈥慘 pr茅cise que les informations sont "furnished" et ne sont donc pas r茅put茅es "filed" aux fins de la Section 18 de l'Exchange Act.
Le texte du d茅p么t n'inclut pas les chiffres ou indicateurs financiers r茅els ; ces d茅tails figurent dans les exhibits r茅f茅renc茅s. Cette divulgation informe les investisseurs de la publication des r茅sultats de fin de trimestre et des documents destin茅s aux investisseurs, tandis que l'avertissement juridique relatif au caract猫re "furnished" limite l'incorporation et la responsabilit茅 au titre de la Section 18.
Perspective Therapeutics, Inc. gab in einer Pressemitteilung seine Finanzergebnisse f眉r das zum 30. Juni 2025 endende Quartal bekannt und stellte diese Pressemitteilung als Exhibit 99.1 in diesem Form 8鈥慘 zur Verf眉gung. Die Einreichung f眉hrt zudem an, dass das Unternehmen eine aktualisierte Unternehmenspr盲sentation auf seiner Website ver枚ffentlicht und diese als Exhibit 99.2 bereitgestellt hat. Das 8鈥慘 stellt klar, dass die Informationen "furnished" sind und daher im Sinne von Section 18 des Exchange Act nicht als "filed" gelten.
Der Text der Einreichung enth盲lt nicht die tats盲chlichen Finanzzahlen oder Kennzahlen; diese Details stehen in den referenzierten Exhibits. Mit dieser Offenlegung werden Anleger dar眉ber informiert, dass Quartalszahlen und Investorenunterlagen ver枚ffentlicht wurden, w盲hrend der rechtliche Hinweis zur "furnished"-Natur die Einbeziehung in andere Dokumente und die Haftung nach Section 18 begrenzt.
FAQ
What did Perspective Therapeutics (CATX) disclose in this 8-K?
Are the financial numbers included directly in the 8-K for CATX?
Where can investors find the detailed results mentioned in the filing?
Does the filing indicate any change in legal status of the disclosures?
What period do the reported results cover?
